Eligibility for heroin-assisted treatment (HAT) among people who inject opioids and are living with HIV in a Canadian setting.
Jan KlimasHuiru DongNadia FairbairnEugenia SocíasRolando BarriosEvan WoodThomas KerrJulio MontanerM-J MilloyPublished in: Addiction science & clinical practice (2018)
In our study of HIV-positive people with a history of injection drug use, approximately 20% of participants were eligible for HAT at ≥ 1 follow-up period. Eligibility was linked to risk factors for sub-optimal HIV/AIDS treatment outcomes, such as homelessness and involvement in the local illicit drug trade, suggesting that scaling-up access to HAT might contribute to achieving optimal HIV treatment in this setting.